350 Episoder

  1. Episode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist

    Publisert: 15.7.2021

  2. Episode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer

    Publisert: 8.7.2021

  3. Episode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,

    Publisert: 1.7.2021

  4. Episode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer

    Publisert: 24.6.2021

  5. Episode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade

    Publisert: 17.6.2021

  6. Episode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug

    Publisert: 10.6.2021

  7. Episode 163: Marilynn Marchione on covering the CRISPR babies scandal

    Publisert: 3.6.2021

  8. Episode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA

    Publisert: 27.5.2021

  9. Episode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity

    Publisert: 20.5.2021

  10. Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit

    Publisert: 13.5.2021

  11. Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging

    Publisert: 6.5.2021

  12. Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt

    Publisert: 29.4.2021

  13. Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside

    Publisert: 22.4.2021

  14. Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19

    Publisert: 15.4.2021

  15. Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines

    Publisert: 8.4.2021

  16. Episode 154: Eleanor Fox on Illumina’s FTC headache, plus Talkspace’s experiment

    Publisert: 1.4.2021

  17. Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week

    Publisert: 25.3.2021

  18. Episode 152: Alison Buttenheim on Europe's vaccine scare, Lilly's Alzheimer's data, & a PR plea

    Publisert: 18.3.2021

  19. Episode 151: Natasha Loder on Covid vaccines, the demise of Watson Health, and a 'synbio' explainer

    Publisert: 11.3.2021

  20. Episode 150: Ashish Jha on Covid-19 optimism, plus pharma cooperation, & the next pandemic phase

    Publisert: 4.3.2021

10 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site